MarketLens

What's Driving Terns Pharmaceuticals' Recent Surge

4 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Driving Phathom Pharmaceuticals' Recent Momentum

5 months ago

What's Driving ZipRecruiter's Recent Stock Surge

5 months ago

What's Driving Fastly's Recent Surge

6 months ago

What's Driving iSpecimen's Recent Stock Surge

4 months ago

Tempus AI stock is soaring and it has Moderna to thank

Tempus AI (TEM) stock soared on August 19, breaking above major moving averages, after third-party clinical breakthroughs triggered a technical short squeeze that signaled renewed bullish control.

MRNA

Stock News•1 months ago

Why This Pharmaceutical Stock Jumped Close to 100% This Week

Shares of a pharmaceutical stock surged nearly 100% this week after agreeing to be acquired by a larger sector firm.

CRNX

Stock News•1 months ago

What's Going on with Vera Therapeutics Stock on Monday?

Vera Therapeutics (VERA) awaits an FDA decision on its rare kidney disease drug, driving investor attention.

VERA

Stock News•3 months ago

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

The FDA granted Breakthrough Therapy Designation to Terns Pharmaceuticals' TERN-701 for treating adult patients with Philadelphia chromosome-positive chronic myeloid leukemia. This status aims to expe...

TERN